Concepedia

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer

A. Alexopoulos, Dimitrios Tryfonopoulos, M. V. Karamouzis, G. Gerasimidis, I Karydas, K. Kandilis, J. Stavrakakis, H. Stavrinides, C. Georganta, Alexandros Ardavanis,

Annals of Oncology · 2003 · 48 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2002 · 1.1K citations

, , +14

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.

Vicente Valero, Frankie A. Holmes, R S Walters et al. · Journal of Clinical Oncology · 1995 · 388 citations

, , +17

Advanced breast cancer: a phase II trial with gemcitabine.

J Carmichael, K. Possinger, P. Phillip et al. · Journal of Clinical Oncology · 1995 · 338 citations

, , +13

Comprehensive Criteria for Assessing Therapy-Induced Toxicity

Jaffer A. Ajani, Susan Welch, Martin N. Raber et al. · Cancer Investigation · 1990 · 240 citations

, , +17

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

M. Spielmann, Antonio Llombart‐Cussac, Salima Kalla et al. · Oncology · 2001 · 140 citations

, , +17